Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

The diagnosis and treatment of cholangiocarcinoma

View through CrossRef
Background: Cholangiocarcinoma (CCA) is the second most common primary hepatic tumor. In recent years, its prognosis has improved because of wide resections and the establishment of local treatment and chemotherapy. Objective: To determine the diagnosis and treatment of cholangiocarcinoma Methods: A cross-sectional study was conducted at First affiliated hospital of Xinjiang Medical University, Urumqi, Xinjiang, China which was performed between December 2023 to July 2024, The total number of patients in our study were 100. The number of Male patients in our study were 55 and female were 45. For all patients, we did diagnostic tests, (CA-19-9), (MRCP, CT Scan). We also took stages of cholangiocarcinoma. For treatment, we used surgery, RFA procedure and chemotherapy. We took parameters of BMI (kg/m2) for all patients. We excluded pregnant women and children in our study. Data was tabulated and analyzed by SPSS version 27. Results: In a current study total 100 patients were enrolled. The minimum age of patients were 53 years and the maximum age of the patients were 78 years. The mean age were 65.10±7.752 years. The minimum BMI of patients were 23 (kg/m2) and the maximum BMI 39 (kg/m2). The minimum ALT were 73 and the maximum were 105 (u/l). The minimum AST were 60 and the maximum were 96 (u/l). The minimum ALP were 140 and the maximum were 250 (u/l).The mean of ALP were 181.80±24.96 (u/l).The frequency of Jaundice were not present in 30 patients and were present in 70 patients. The frequency of Itchy skin were not present in 65 patients and were present in 35 patients. The frequency of dark urine were not present in 80 patients and were present in 20 patients. In Figure 3, we can see the treatment of cholangiocarcinoma, (Biliary drainage 10%, Chemotherapy 15%, RFA 35%, and Surgery in 40% of patients).The frequency of CA-19-9 were negative in 25 patients and were positive in 75 patients. P-Value were 0.03. The frequency of diagnose of cholangiocarcinoma on CT scan were 30 and diagnose on MRCP were 70 and its percentage were 70%.In our study P-Value were less than (< 0.05). Conclusion: We concluded that Cholangiocarcinoma best and early diagnosis on MRCP. Surgery and RFA are the two good methods for the treatment of cholangiocarcinoma. Stage 2 is the most common stage of cholangiocarcinoma in our study.
Title: The diagnosis and treatment of cholangiocarcinoma
Description:
Background: Cholangiocarcinoma (CCA) is the second most common primary hepatic tumor.
In recent years, its prognosis has improved because of wide resections and the establishment of local treatment and chemotherapy.
Objective: To determine the diagnosis and treatment of cholangiocarcinoma Methods: A cross-sectional study was conducted at First affiliated hospital of Xinjiang Medical University, Urumqi, Xinjiang, China which was performed between December 2023 to July 2024, The total number of patients in our study were 100.
The number of Male patients in our study were 55 and female were 45.
For all patients, we did diagnostic tests, (CA-19-9), (MRCP, CT Scan).
We also took stages of cholangiocarcinoma.
For treatment, we used surgery, RFA procedure and chemotherapy.
We took parameters of BMI (kg/m2) for all patients.
We excluded pregnant women and children in our study.
Data was tabulated and analyzed by SPSS version 27.
Results: In a current study total 100 patients were enrolled.
The minimum age of patients were 53 years and the maximum age of the patients were 78 years.
The mean age were 65.
10±7.
752 years.
The minimum BMI of patients were 23 (kg/m2) and the maximum BMI 39 (kg/m2).
The minimum ALT were 73 and the maximum were 105 (u/l).
The minimum AST were 60 and the maximum were 96 (u/l).
The minimum ALP were 140 and the maximum were 250 (u/l).
The mean of ALP were 181.
80±24.
96 (u/l).
The frequency of Jaundice were not present in 30 patients and were present in 70 patients.
The frequency of Itchy skin were not present in 65 patients and were present in 35 patients.
The frequency of dark urine were not present in 80 patients and were present in 20 patients.
In Figure 3, we can see the treatment of cholangiocarcinoma, (Biliary drainage 10%, Chemotherapy 15%, RFA 35%, and Surgery in 40% of patients).
The frequency of CA-19-9 were negative in 25 patients and were positive in 75 patients.
P-Value were 0.
03.
The frequency of diagnose of cholangiocarcinoma on CT scan were 30 and diagnose on MRCP were 70 and its percentage were 70%.
In our study P-Value were less than (< 0.
05).
Conclusion: We concluded that Cholangiocarcinoma best and early diagnosis on MRCP.
Surgery and RFA are the two good methods for the treatment of cholangiocarcinoma.
Stage 2 is the most common stage of cholangiocarcinoma in our study.

Related Results

c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma
c‐erbB‐2 and c‐Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma Aims: The c‐erbB‐2 and c‐Met proto‐oncogenes are important for ...
Abstract 1400: C1GALT1 regulates malignant phenotypes of cholangiocarcinoma cells
Abstract 1400: C1GALT1 regulates malignant phenotypes of cholangiocarcinoma cells
Abstract Identifying molecular targets for cholangiocarcinoma is an urgent need to overcome the treatment failure and death from cancer cell invasion and metastasis....
Aberrant DNA Methylation in Cholangiocarcinoma
Aberrant DNA Methylation in Cholangiocarcinoma
Cholangiocarcinoma is an epithelial malignancy arising in the region between the intrahepatic bile ducts and the ampulla of Vater at the distal end of the common bile duct. The eff...
Data from miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth
Data from miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth
<div>Abstract<p>miRNAs are a group of small, noncoding RNAs that modulate the translation of genes by binding to specific target sites in the target mRNA. This study in...
Data from miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth
Data from miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth
<div>Abstract<p>miRNAs are a group of small, noncoding RNAs that modulate the translation of genes by binding to specific target sites in the target mRNA. This study in...
Regional versus Extended Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a randomized controlled trial protocol
Regional versus Extended Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a randomized controlled trial protocol
ABSTRACTIntroductionThe mainstay treatment for intrahepatic cholangiocarcinoma is surgical resection, the impact of lymph node dissection and the scope of lymph node dissection for...
Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma
Expression and Antitumor Effects of TRAIL in Human Cholangiocarcinoma
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)/Apo2L has been recently identified as important in promoting programmed cell death in breast and colon adenoca...

Back to Top